Polypharmacy and comorbidities are not higher at diagnosis in patients with polymyalgia rheumatica compared to osteoarthritis
At the time of diagnosis, PMR patients do not show an increased comorbidity index nor number of drugs assumed compared to OA controls.
Authors
- Marco Amedeo Cimmino (ORCID: https://orcid.org/0000-0002-6956-7860)
- P. Clini (ORCID: https://orcid.org/0009-0004-4258-7185)
- Maurizio Cutolo (ORCID: https://orcid.org/0000-0002-5396-0932)
- Elvis Hysa (ORCID: https://orcid.org/0000-0002-6970-0983)
- Dario Camellino (ORCID: https://orcid.org/0000-0001-6384-6458)
Institutions
- Center for Rheumatology (US)
- University of Genoa (IT)
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2025-03-09
- DOI
- https://doi.org/10.55563/clinexprheumatol/z9264f
- Primary Topic
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Type
- article
- Field-Weighted Citation Impact
- 0.00